CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
CERO THERAPEUTICS HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $253.05K
- P/E (TTM)
- –
- Dividend yield
- 172833.33%
Cero Therapeutics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Market Cap | $429.79K | $197.05M |
| Enterprise Value | -$432.97K | $106.56M |
Income (trailing twelve months)
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Net Income | -$16.31M | -$22.46M |
Returns
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Return on Assets (ROA) | -402.6% | -41.0% |
Balance sheet
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $862.76K | $62.42M |
| Net Cash (Debt) | $862.76K | $15.68M |
| Net Cash Per Share | $0.01 | $0.65 |
| Equity (Book Value) | -$30.51M | $48.79M |
| Book Value Per Share | -$0.43 | $1.36 |
| Tangible Book Value | -$30.51M | $23.06M |
| Working Capital | -$30.86M | $75.77M |
Financial position
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Current Ratio | 0.05 | 3.30 |
| Quick Ratio | 0.03 | 2.39 |
Efficiency
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Profits Per Employee | -$2.04M | -$732.08K |
| Employee Count | 8 | 73 |
Dividends and yields
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Earnings Yield | -3795.3% | -21.2% |
| Dividend Yield | 172833.0% | 1.83% |
| Shareholder Yield | 172833.0% | 0.00% |
| Dividend Per Share | $10.37 | $0.83 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 71,631,000 | 59,128,900 |
| Float | 36,850,000 | 48,744,500 |
| Shares Held by Insiders | 48.6% | 11.8% |
| Shares Held by Institutions | 0.00% | 59.4% |
Scores
| Measure | Cero Therapeutics | Industry median |
|---|---|---|
| Altman Z-Score | -91.51 | 0.10 |
Calculated by StockData from Cero Therapeutics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.